Vanguard Personalized Indexing Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$924K Buy
3,314
+161
+5% +$46.4K 0.01% 970
2025
Q4
$955K Buy
3,153
+9
+0.3% +$2.81K 0.01% 934
2025
Q3
$882K Buy
3,144
+121
+4% +$32.9K 0.01% 970
2025
Q2
$730K Buy
3,023
+900
+42% +$213K 0.01% 1027
2025
Q1
$517K Sell
2,123
-250
-11% -$75.2K 0.01% 1098
2024
Q4
$780K Buy
2,373
+522
+28% +$177K 0.01% 897
2024
Q3
$619K Buy
1,851
+120
+7% +$38.1K 0.01% 1003
2024
Q2
$473K Sell
1,731
-152
-8% -$44.2K 0.01% 1068
2024
Q1
$651K Buy
1,883
+305
+19% +$100K 0.01% 873
2023
Q4
$510K Buy
1,578
+332
+27% +$104K 0.01% 991
2023
Q3
$447K Buy
1,246
+55
+5% +$21.2K 0.01% 926
2023
Q2
$452K Sell
1,191
-194
-14% -$78.9K 0.01% 936
2023
Q1
$663K Sell
1,385
-150
-10% -$70.2K 0.02% 735
2022
Q4
$645K Buy
1,535
+568
+59% +$229K 0.03% 697
2022
Q3
$403K Buy
967
+349
+56% +$174K 0.02% 854
2022
Q2
$306K Sell
618
-190
-24% -$99K 0.01% 981
2022
Q1
$455K Sell
808
-44
-5% -$26.5K 0.02% 863
2021
Q4
$644K Buy
852
+245
+40% +$183K 0.04% 599
2021
Q3
$453K Sell
607
-45
-7% -$33.7K 0.04% 571
2021
Q2
$420K Buy
652
+23
+4% +$14K 0.04% 568
2021
Q1
$359K Buy
629
+268
+74% +$159K 0.05% 437
2020
Q4
$210K Buy
+361
New +$206K 0.05% 491

Other funds holding BIO